Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after

By Tykodi Scott S   Sandmaier Brenda M   Warren Edus H   Thompson John A  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 6, 2011-06 ,pp. : 763-773

Informa Healthcare

Access to resources Recommend Favorite

Gene- and immunotherapy for hepatocellular carcinoma

By Palmer Daniel H   Hussain Syed A   Johnson Philip J  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 4, 2005-04 ,pp. : 507-523

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy of hepatocellular carcinoma

By Butterfield Lisa H   Ribas Antoni  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 123-133

Informa Healthcare

Access to resources Recommend Favorite

Prognosis markers for metastatic renal cell carcinoma: quantitative proteomics approach

By Dihazi Hassan  

Expert Review of Proteomics, Vol. 10, Iss. 1, 2013-02 ,pp. : 21-24

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab for metastatic renal cell carcinoma: a monoclonal antibody in a sea of small molecules

By Pal Sumanta Kumar   Figlin Robert A  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1517-1520

Informa Healthcare

Access to resources Recommend Favorite